Kirin

A Japanese beer and pharma conglomerate ranking #3 globally is the kind of thing that only makes sense when you strip away brand mythology and look at pure capital efficiency. Kirin's C=30 is almost aggressively low — this is a brand that exists in spreadsheets more than conversations. The 8.84% stock gain says the market doesn't care about the culture gap.